Neuroeffector mechanisms involved in the regulation of dog splenic arterial tone

Journal of Pharmacological Sciences

Volumn 92, Issue 2, 2003, Pages 84-92

  Chiba, Shigetoshi ^a   Yang, Xiao Ping ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine 5 triphosphate; Isolated dog splenic artery; Neuropeptide Y; Noradrenaline; Periarterial nerve electrical stimulation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 [[5 ETHYL 3 [[2' (1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 1,3,4 THIADIAZOLIN 2 YLIDENE]CARBAMOYL] 1 CYCLOPENTENECARBOXYLIC ACID; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ANGIOTENSINASE; CALCIUM CHANNEL; DILTIAZEM; GUANETHIDINE; IMIPRAMINE; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y [13-36]; NEUROTRANSMITTER; NORADRENALIN; OMEGA CONOTOXIN; PHENTOLAMINE; PRAZOSIN; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RAUWOLSCINE; RESERPINE; SURAMIN; TETRODOTOXIN; TYRAMINE; UNINDEXED DRUG;

ARTERY TONE; CRYOPRESERVATION; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RESPONSE; ISOLATED ARTERY; NERVE STIMULATION; NONHUMAN; REVIEW; SPLEEN ARTERY; SYMPATHETIC NERVE CELL; VASOCONSTRICTION;

EID: 0037966169     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.84     Document Type: Review

References (63)

1. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, aminoacids and nitric oxide. Pharmacol Rev. 1996;48:113-179.
2. Burnstock G. Purinergic nerves. Pharmacol Rev. 1972;24:509-560.
3. Carlsson A, Hillarp N-Å, Hökfelt B. The concomitant release of adenosine triphosphate and catecholamines from the adrenal medulla. J Biol Chem. 1975;227:243-252.
4. Lagercrantz H, Stjärne L. Evidence that most noradrenaline is stored without ATP in sympathetic large dense cored nerve vesicles. Nature. 1974;249:843-844.
5. Fried G. Small noradrenergic storage vesicles isolated from rat vas deferens - Biochemical and morphological characterization. Acta Physiol Scand. 1980;93 Suppl:1-28.
6. Burnstock G. Do some nerve cells release more than one transmitter? Neuroscience. 1976;1:239-248.
7. Westfall DP, Stitzel RE, Rowe JN. The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur J Pharmacol. 1978;50:27-38.
8. Brock JA, Cunnane TC. Electrical activity at the sympathetic neuroeffector junction in the guinea-pig vas deferens. J Physiol (Lond). 1988;399:607-632.
9. Lundberg JM, Tatemoto K, Terenius L, et al. Localization of the peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA. 1982;79:4471-4475.
10. Lundberg JM, Terenius L, Hökfelt T, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982;116:477-480.
11. Lundberg JM, Terunius L, Hökfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett. 1983;42:167-172.
12. Hongo K, Chiba S. A new method for measuring vascular responsiveness of relatively larger arteries of dogs. J Pharmacol Methods. 1983;9:83-91.
13. Tsuji T, Chiba S. Potentiating effect of methysergide on norepinephrine-induced constriction of the internal carotid artery of the dog. Jpn J Pharmacol. 1984;34:95-100.
14. Chiba S, Tsukada M. Different sensitivity of blocking effect of α-adrenoceptor blocking agents on vascular responses to intraluminal norepinephrine and periarterial stimulation in isolated dog arteries. Jpn J Pharmacol. 1985;38:83-89.
15. Ren L-M, Nakane T, Chiba S. Purinergic and adrenergic transmission and their presynaptic modulation in canine isolated perfused splenic arteries. Eur J Pharmacol. 1996;295:61-68.
16. Haniuda K, Nakane T, Chiba S. Different contributions of ATP and noradrenaline to neurotransmission in the isolated canine intermediate auricular artery. Eur J Pharmacol. 1997;333:163-168.
17. Kennedy C, Saville VL, Burnstock G. The contributions of noradrenaline and ATP to the responses of rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol. 1986;122:291-300.
18. Machaly M, Dalziel HH, Sneddon P. Evidence for ATP as a cotransmitter in dog mesenteric artery. Eur J Pharmacol. 1988;147:83-91.
19. 2-autoinhibition in a vascular neuroeffector junction where ATP and noradrenaline act as co-transmitters. Br J Pharmacol. 1990;99:279-284.
20. Sjöblom-Widfeldt N, Gustafsson H, Nilsson H. Transmitter characteristics of small mesenteric arteries from the rat. Acta Physiol Scand. 1990;138:203-212.
21. Yang X-P, Chiba S. Pharmacological analysis of the double peaked vasoconstrictor responses to periarterial electric stimulation. J Auton Pharmacol. 1998;18:343-347.
22. Yang P-X, Chiba S. Perivascular purinergic nerve-induced vasoconstrictions in canine isolated splenic arteries. Jpn J Pharmacol. 2000;82:71-73.
23. Yang P-X, Chiba S. Pharmacological analysis of vasoconstrictor responses to periarterial purinergic nerve stimulation. J Auton Pharmacol. 1999;19:359-364.
24. Yang X-P, Chiba S. Effects of reserpine on nerve stimulation-induced constrictions in isolated canine splenic artery. Clin Exp Pharmacol Physiol. In press 2003.
25. Langer SZ, Pinto JEB. Possible involvement of a transmitter different from norepinephrine in the residual responses to nerve stimulation of the cat nictitating membrane after pretreatment with reserpine. J Pharmacol Exp Ther. 1976;196:697-731.
26. Suzuki H, Mishima S, Miyahara H. Effects of reserpine on electrical responses evoked by perivascular nerve stimulation in the rabbit ear artery. Biomed Res. 1984;5:259-265.
27. Sneddon P, Westfall DP. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol (Lond). 1984;34:561-580.
28. Kirkpatrick K, Burnstock G. Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine. Eur J Pharmacol. 1987;138:207-214.
29. Sneddon P, Burnstock G. ATP as a neurotransmitter in rat tail artery. Eur J Pharmacol. 1984;106:149-152.
30. Shore PA. Transport and storage of biogenic amines. Annu Rev Pharmacol. 1972;12:209-226.
31. Koelle GB. Drugs acting synaptic and neuroeffector junctional sites. In: Goodman LS, Gilman A, editors. The Pharmacological Basis of Therapeutics. 4th ed. New York: MacMillan Publishing Co., Inc.; 1970. p. 402-441.
32. Furchgott RF, Kirpekar M, Rieker M, Schwab A. Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J Pharmacol Exp Ther. 1963;142:39-58.
33. Trendelenburg U. The effect of sympathetic nerve stimulation on isolated atria of guinea pigs and rabbit pretreated with reserpine. J Pharmacol Exp Ther. 1965;147:313-318.
34. Toda N, Yamasaki Y, Fujiwara M. Response to sympathetic nerve stimulation and noradrenaline in atria treated with reserpine and in atria from rabbits pretreated with reserpine. Jpn J Pharmacol. 1970;20:517-529.
35. Hukovic S. Responses of the isolated sympathetic nerve-ductus deferens preparation of the guinea-pig. Br J Pharmacol. 1961;16:188-194.
36. Burn JH, Rand MJ. The effect of precursors of noradrenaline on the response to tyramine and sympathetic stimulation. Br J Pharmacol. 1960;15:47-55.
37. Yang X-P, Chiba S. Dissociation of inhibitory effects of guanethidine on adrenergic and on purinergic transmission in isolated canine splenic artery. Eur J Pharmacol. 1999;380:5-11.
38. Yang X-P, Chiba S. Effects of imipramine, an uptake inhibitor, on double-peaked constrictor responses to periarterial nerve stimulation in isolated, perfused canine splenic arteries. Jpn J Pharmacol. 1999;79:461-466.
39. Yang X-P, Chiba S. Adrenergic-purinergic interactions on vasoconstrictor responses to periarterial electric nerve stimulation in canine splenic arteries. J Auton Pharmacol. 1999;19:139-144.
40. Mulkey RM, Zucker RS. Action potentials must admit calcium to evoke transmitter release. Nature. 1991;350:152-155.
41. Maggi CA, Pattacchini R, Santicioli P, et al. The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves. Naunyn Schmiedebergs Arch Pharmacol. 1988;338:107-113.
42. Ren L-M, Nakane T, Chiba S. Differential effects of ω-conotoxin GVIA and tetrodotoxin on vasoconstrictions evoked by electrical stimulation and nicotinic receptor stimulation in canine isolated, perfused splenic arteries. Br J Pharmacol. 1994;111:1321-1327.
43. Yang X-P, Chiba S. Effects of ω-conotoxin GVIA and diltiazem on double peaked vasoconstrictor responses to periarterial electric nerve stimulation in isolated canine splenic artery. Br J Pharmacol. 2000;129:47-52.
44. Yang X-P, Chiba S. Differential effects of ω-conotoxin GVIA, tetrodotoxin and prolonged cold storage on purinergic and adrenergic transmission in isolated canine splenic artery. J Cardiovasc Pharmacol. 2003;36 Suppl 2:S5-S8.
45. Kao CY. Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena. Pharmacol Rev. 1966;18:997-1049.
46. Brock JA, Cunnane TC. Relationship between the nerve action potential and transmitter release from sympathetic post-ganglionic nerve terminals. Nature. 1987;326:605-607.
47. Åstrand P, Stjärne L. ATP as a sympathetic co-transmitter in rat vascular nerves: Further evidence that individual release sites respond to nerve impulses by intermittent release of single quanta. Acta Physiol Scand. 1989;136:355-365.
48. Yang X-P, Chiba S. Differential blocking effects of tetrodotoxin on double-peaked vasoconstrictor responses to periarterial nerve stimulation in canine, isolated, perfused splenic artery. Clin Exp Pharmacol Physiol. 1999;26:784-789.
49. Yang X-P, Chiba S. Effects of prolonged cold storage on purinergic and adrenergic components of sympathetic co-transmission in isolated canine splenic arteries. Jpn J Pharmacol. 1999;81:163-169.
50. Yang X-P, Chiba S. Effects of prolonged cold storage on double peaked vasoconstrictor responses to periarterial nerve stimulation in isolated canine splenic arteries. Br J Pharmacol. 1999;126:1810-1814.
51. Yang X-P, Chiba S. Angiotensin II receptor subtypes involved in the modulation of purinergic and adrenergic vasconstrictions to periarterial electric nerve stimulation in the canine splenic artery. J Cardiovasc Pharmacol. 2002;41 Suppl 1:S49-S52.
52. Fried G, Lundberg JM, Theodorsson-Norheim E. Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol Scand. 1985;127:145-154.
53. Fried G, Terenius L, Hökfelt T, Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci. 1985;5:450-458.
54. Yang PX, Chiba S. Effects of neuropeptide Y on double-peaked constrictor responses to periarterial nerve stimulation in isolated, perfused canine splenic arteries. Jpn J Pharmacol. 2000;82:67-70.
55. Malmström RE. Pharmacology of neuropeptide Y receptor antagonists: Focus on cardiovascular functions. Eur J Pharmacol. 2002;447:11-30.
56. Chiba S, Yang P-X. Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: Role of neuropeptide Y. Auton Autacoid Pharmacol. 2003;22:187-197.
57. 2 receptor subtype in canine splenic arteries. Auton Autacoid Pharmacol. 2002;22:119-126.
58. 34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery. Jpn J Pharmacol. 2000;83:197-205.
59. 1 receptor antagonist BIBP3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries. Br J Pharmacol. 1999;130:1699-1705.
60. 1 receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic artery. J Cardiovas Pharmacol. 2001; 38 Suppl 1:S17-S20.
61. 1A-blockade. Jpn J Pharmacol. 2000;84:360-362.
62. 1-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries. Br J Pharmacol. 2001;132:1852-1858.
63. 1B-adrenoceptors in the neurovascular junction of canine splenic arteries. Eur J Pharmacol. 2003;466:311-315.